| __timestamp | Bio-Techne Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 241751000 |
| Thursday, January 1, 2015 | 40853000 | 322292000 |
| Friday, January 1, 2016 | 45187000 | 344320000 |
| Sunday, January 1, 2017 | 53514000 | 374644000 |
| Monday, January 1, 2018 | 55329000 | 414604000 |
| Tuesday, January 1, 2019 | 62413000 | 466000000 |
| Wednesday, January 1, 2020 | 65192000 | 535000000 |
| Friday, January 1, 2021 | 70603000 | 643000000 |
| Saturday, January 1, 2022 | 87140000 | 833000000 |
| Sunday, January 1, 2023 | 92493000 | 899625000 |
| Monday, January 1, 2024 | 96664000 | 901530000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Bio-Techne Corporation and Ionis Pharmaceuticals, Inc. have demonstrated contrasting yet fascinating trajectories in their R&D spending.
Bio-Techne Corporation has steadily increased its R&D expenses, growing by approximately 212% from 2014 to 2023. This consistent investment underscores their commitment to pioneering advancements in the biotech sector. In contrast, Ionis Pharmaceuticals, Inc. has shown a more aggressive approach, with R&D expenses peaking in 2023 at nearly 900% of their 2014 levels. This surge highlights Ionis's strategic focus on breakthrough therapies.
While Bio-Techne's growth reflects a stable and sustainable strategy, Ionis's rapid escalation in R&D spending suggests a bold pursuit of cutting-edge solutions. As we look to the future, these investments will likely shape the next wave of biotech innovations.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation